For patients with rheumatoid arthritis (RA) with sustained low disease activity (LDA), structured tapering of biologic or ...

For patients with inflammatory arthritis, holding certain disease-modifying antirheumatic drugs (DMARDs), namely select ...

Please provide your email address to receive an email when new articles are posted on . Antimalarials, azathioprine, colchicine, cyclosporine, sulfasalazine and tacrolimus are deemed compatible with ...

Arthritis, a chronic condition characterized by inflammation, is a common disease in the United States. Approximately 43.5% of people in the US living with arthritis experience some sort of limitation ...

Combining an anticancer drug with an antirheumatic produces improved effects against tumors, scientists have discovered. The discovery opens a new path for drug-drug synergy. Scientists at EPFL and ...

Only slightly more than half of patients with newly diagnosed rheumatoid arthritis initiated therapy within 1 year. Objectives: To determine the rate of timely disease-modifying antirheumatic drug ...